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In the United States and many other coun-
tries, the prevalence ofasthma in both adults
and children is rising, an increase that cannot
be reconciled simply by changes in diagnos-
tic categorization. The increase in prevalence
is too rapid to be explained by alterations in
the gene pool and is thus a growing interest
in the environment and asthma. Data from
the second National Health and Nutrition
Examination Survey (NHANES II) indicate
that in 1987 there were approximately 25
million individuals in the United States who
currently or previously had asthma or symp-
toms associated with asthma. Illness associat-
ed with asthma accounts for an estimated 27
million patient visits and 470,000 hospital
admissions annually; this translates into an
estimated loss of3 million workdays and 90
million days ofrestricted activity. Asthma is
more prevalent among6 to 11-year-old black
children than among white children at the
same age, and an even higher prevalence is
noted among children of Puerto Rican
descent. Although asthma deaths are infre-
quent, mortality rates have increased 66%
since 1980. The costs related to this disease
are enormous, with an estimated cost in the
United States in 1990 of$6.2 billion.
There is mounting evidence that air pol-
lutants are involved in exacerbating asthma.
Controlled laboratory exposure studies show
that specific air pollutants stimulate bron-
choconstriction or airway inflammation.
The U.S. Clean Air Act of 1970 provides
special consideration to criteria air pollu-
tants including 03, SO2, particulate matter
<10 pm (PM1O), NO., and Pb. National
Ambient Air Quality Standards for these
pollutants are set by the U.S. Environmental
Protection Agency (EPA), with particular
concern for populations at risk. Asthmatics
are more sensitive to several of these pollu-
tants and therefore constitute a susceptible
population. The EPA has considerable inter-
est in asthma as a public health and an envi-
ronmental health issue.
Workshop Goals and Structure
The EPA and several other public health
agencies jointly sponsored a workshop 7-9
May 1996, in Chapel Hill, North Carolina,
to discuss the possible links between environ-
mental pollutants and asthma. The work-
shop's objective was to review recent findings
pointing to an association between environ-
mental pollutants and asthma. In addition,
theworkshop provided aplatform to discuss
recent advances and identified major scien-
tific uncertainties that limited risk assess-
ment. In keeping with these objectives, the
EPA specifically needs to determine the
extent to which asthmatics represent a high
risk population for air pollutants and char-
acterize the nature of the risk, which
includes dose-response assessments, riskfac-
tors, and mechanistic information.
The structure of the workshop includ-
ed four scientific sessions with five to eight
plenary speakers and one or two co-chair-
men (see list). At the end ofeach session, a
panel of experts addressed specific ques-
tions facilitated by a rapporteur (see list).
The workshop brought together basic sci-
entists, clinicians, and epidemiologists
from academia and various public health
agencies, all of whom share an interest in
asthma and the environment.
Session I: TheAsthma Phenomenon
This session set the stage for the workshop,
and provided everyone with the big picture.
Worldwide demography and changes over
the past quarter-century were reviewed.
Asthma is an increasingly prevalent diagnosis,
especially among children in affluent coun-
tries that have become heavily urbanized.
Australasia has an exceptionally high preva-
lence for as yet unknown reasons. Chinese
Americans in Hawaii have a very low preva-
lence compared to other ethnic Hawaiian
groups. In the continental United States,
asthma prevalence is increasing among black
children, particularly in certain areas ofNew
York and Chicago. This trend is consistent
with an effect ofurbanization, but not with
increasing affluence.
Risk factors for the development of
asthma include both a genetic base and
environmental triggers such as postnatal
exposure to maternal cigarette smoke.
Ambient air pollutants may cause nonspe-
cific airway reactivity and inflammation,
provoke acute bronchospasm, and enhance
the response of allergic asthmatics to spe-
cific antigen challenge. The extensive epi-
demiology linking ambient air pollution-
especially involving ozone and particulate
matter-with asthma exacerbations was
emphasized. Indoor air contaminants asso-
ciated with asthma include indoor antigens
(e.g., housedust mite, cat, cockroach), bio-
logicals such as endotoxin, and various
gases and particles ofnonbiological origin.
The general immunologic mechanisms
in asthma and the specific role ofthe CD4+-
T lymphocyte of the TH2 category were
reviewed. Viral upper respiratory tract infec-
tions were noted to play an important role
in asthma exacerbations. In addition, acute
viral infections may be critical events in the
initial development ofthe asthmatic state. If
inhaled pollutants interact with respiratory
epithelium to enhance susceptibility to viral
infection, this might indirectly influence
asthma pathogenesis and exacerbations.
Finally, in considering air pollution-asthma
interactions, the role of the epithelial lining
ofthe airways was considered; this is the pri-
mary target of inhaled reactive pollutants,
which interact with submucosal cellular and
vascular elements through epithelial
cytokines and chemokines, neural pathways,
and perhaps mediators like nitric oxide.
Session II: Environmental
Epidemiology
This session reviewed the most recent epi-
demiology studies linking environmental
pollutants and asthma. Although there is
considerable evidence that ambient air pol-
lution can exacerbate asthma, aggregate data
on temporal changes in asthma prevalence
do not support a relationship between the
initiation of asthma cases and ambient air
pollutants. Despite a monotonic increase in
asthma deaths in the United States between
1979 and 1989, ambient concentrations of
particulates and sulfur oxides have steadily
declined. Furthermore, asthma mortality
does not appear related to differences in air
pollution concentrations across cities.
The issue ofwheezing before age 6 was
examined as a risk factor for childhood
asthma. Results from studies in Arizona
suggest that there are two types ofwheezing
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illnesses occurring before age 3. One form
is more common, has a good prognosis,
and is associated with lower levels of lung
function at birth. The second, a more per-
sistent form, is associated with normal lev-
els oflung function at birth but diminished
lung function at age 6. Children with this
form have many ofthe risk factors that are
associated with asthma later in life (family
history ofasthma, personal history ofaller-
gic disease, high IgE levels, etc.).
The effects of long-term residence in
communities with high ambient ozone levels
on the risk ofdeveloping asthma have been
studied among Seventh Day Adventists in
California. For participants free ofasthma in
1977, the 15-year cumulative incidence of
doctor-diagnosed asthma was 2.8 and 3.6%
in males and females, respectively, and was
related to 8-hr ambient ozone concentration
for males, but not for females. Among males
who had doctor-diagnosed asthma but no
symptoms in 1977, the development ofnew
asthma symptoms was related to ozone con-
centration.
The difficulties in showing convincingly
that long-term exposure to ambient particu-
lates causes asthma is in part related to
absence of control for environmental aller-
gens from dust mites, pets, and pollen.
Nevertheless, a number of studies show
positive associations of ambient particulate
levels with hospital admissions for asthma
and with acute symptoms, bronchodilator
use, and lung function in panels ofasthmat-
ics. A positive association between the self-
reported frequency oftruck traffic, but not
automobile traffic, was reported near the
residence of study subjects in two German
cities, Bocchum and Miinster. The preva-
lence odds ratio for the association of
wheezing and frequent truck traffic was
1.5-1.6, and for symptoms ofallergic rhini-
tis was 1.7-2.0. There was no indication of
confounding by smoking, pets, or markers
of socioeconomic status. Because misclassi-
fication resulting from self-reports oftraffic
exposure cannot be ruled out, there is a
need for further investigation using more
refined measures ofexposure.
Work funded by the National Institute
ofAllergy and Infectious Diseases through
the National Cooperative Inner CityAsthma
Study was described. These studies focus on
minority populations, with objectives to
identify risk factors and effective, interven-
tions that are culturally appropriate and
geared toward self-management. The health
outcomes include hospital and emergency
room visits and absences from school or
work. The National Institute for
Occupational Health and Safety provided an
overview of occupational asthma research
and surveillance at the Institute. The
National Institute of Environmental Health
Sciences proposed the work "Environmental
Interventions in the Primary Prevention of
Asthma in Children." Five hundred infants
from lower socioeconomic families with an
asthma history will be randomized at birth
into intervention and control groups and
assessed for asthma symptoms. Environ-
mental interventions to protect infants from
exposure to mite and cockroach allergenswill
be implemented. Overall, these presentations
point to a need for expanded research into
environmental factors associated with the
induction of asthma, particularly among
infants andyoungchildren.
Session III: Controlled Exposure
Studies
This session focused on the role of acute
exposure to specific environmental pollu-
tants in the asthmatic response and
addressed the following questions: Does
ozone sensitize asthmatic airways and
increase susceptibility to a subsequent aller-
gen challenge? Is the inflammatory
response of asthmatics to ozone different
from normal individuals? Do moderate
asthmatics respond differently to ozone
than mild asthmatics? Are animal models
instructive in understanding the response
ofasthmatics to pollutants?
Exposures to ozone under controlled
conditions have demonstrated similar sensi-
tivity for asthmatic and normal subjects, at
least as measured by lung function symp-
toms. However, mechanisms unrelated to
direct ozone-induced bronchoconstriction
could enhance sensitivity of asthmatics.
Recently, it was reported that inhalation of
0.1 ppm ozone sensitized asthmatic airways,
making them more susceptible to a subse-
quent challenge with allergen. Two presenta-
tions further examined the ozone-allergen
interaction. One group was unable to con-
firm increased responsiveness to allergen in
asthmatics exposed to 0.2 ppm ozone for 1
hr, with intermittent exercise. These findings
support recent studies for mild asthmatics
exposed to 0.1 ppm ozone for 1 hr at rest,
but contrast with other investigators who
observed increased bronchial responsiveness
in asthmatics exposed to 0.25 ppm ozone for
3 hr with moderate exercise. The interaction
between ozone and allergen in asthmatics has
also been assessed using nasal lavage. Mild
resting asthmatics exposed to 0.4 ppm ozone
required less allergen instilled into the nose
to elicit symptoms. Thus, there are sugges-
tions that prior ozone exposure sensitizes the
nose or airways to a subsequent allergen chal-
lenge, but furtherwork is needed.
Subsequent presentations focused on
direct effects of ozone on the induction of
inflammatory mediators in asthmatics.
Ozone-induced changes in bronchoalveolar
lavage (BAL) protein levels were similar
between normal and asthmatic subjects, but
asthmatics had a more pronounced poly-
morphonuclear neutrophils (PMN) influx.
This agrees with the data using nasal lavage
in which higher numbers ofPMNs, as well
as eosinophils, in asthmatics exposed to
ozone were compared with normal subjects.
Mild asthmatics exposed to 0.2 ppm ozone
for 4 hrwith intermittent moderate exercise
had increased BAL levels of PMNs,
eosinophils, and lymphocytes. Additional
data showed increased numbers of
eosinophils and eosinophil cationic protein
(ECP) in nasal lavage fluid of asthmatics
exposed to ozone. These studies suggest
that asthmatics may respond to ozone with
an influx of eosinophils. Furthermore, it
was observed that moderate asthmatics
exposed to 0.16 ppm ozone for 7.6 hr had
more symptoms and greater decrements in
forced expiratory volume in 1 sec (FEV1)
and FEVI/forced vital capacity than normal
subjects. Asthmatics requiring inhaled beta
agonists during the exposure had even
greater decrements in lung function. Future
work with more significantly obstructed
asthmatics may help resolve the discrepancy
between epidemiology, suggesting that asth-
matics are more sensitive to ozone, and
findings from controlled exposure studies.
The clinical data, nevertheless, provide
compelling evidence that ozone exposure
directly induces substantial bronchocon-
striction in moderate asthmatics.
Animal models are potentially useful for
studying biological mechanisms responsible
for the sensitization phase ofasthma. It was
demonstrated that immediate hypersensitiv-
ity responses in allergic rats were associated
with high titers of IgE antibody in serum,
but that immune-mediated inflammation
and airway hyperresponsiveness were inde-
pendent of reaginic antibody levels.
Intriguing data were presented indicating
that these latter clinical features of asthma
could be transferred to recipient animals by
injection oflymphocytes. Pretreatmentwith
IL-12 appeared to block allergic inflamma-
tion by increasing THI cytokines (interfer-
on y and TNFa) in BAL fluid of mice.
Finally, exposure to 5 ppm NO2 after sensi-
tization and antigen challenge up regulated
lymphocyte function, allergen-specific anti-
body levels, and immune mediated pul-
monary function in the lung.
Session IV: Mechanisms ofResponse
inAsthma
The primary focus of the presentations in
the last session was to explore the mecha-
nisms and factors involved in the exacerba-
tion and persistence ofasthma.
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The complex cellular and molecular
processes that contribute to airway inflam-
mation were reviewed; it was emphasized
that they are interactive, redundant, and self-
perpetuating-a recurrent theme in this ses-
sion. The important role ofcytokines in the
initiation and resolution ofthe inflammatory
response was emphasized. New data suggest
that cytokines are encrypted and presented
with local, site-specific actions. The local
cytokine milieu includes several cytokines
produced from different cells or varying
ratios ofcytokines produced by a single cell
type. For example, when TH2 cells are chal-
lenged with increasing concentrations of
antigen, the ratio ofrelease oftwo cytokines
(IL-4: interferon y) will change from a TH2
through a THO to a TH1 profile as the con-
centration ofantigen increases.
The pathologic processes in asthma
have been recognized to include dysregula-
tion of inflammation and injury processes.
Newwork is now pointing to dysregulation
of cell death and cell repair processes. For
example, data obtained from in vitrostudies
indicated that altered apoptosis is present in
subjects with peripheral eosinophilia.
Respiratory viral infections (rhinovirus
and respiratorysyncytial virus) and their role
in the exacerbation of asthma were dis-
cussed. Experimental rhinovirus infection
can be performed in controlled human chal-
lenge settings and in vitro and the virus
assayed via polymerase chain reaction in
nasal secretions, lavage fluid, and biopsy
samples. Rhinovirus infection causes few
cytopathologic changes, but induces an
immune response that up regulates preexist-
ing inflammation in the asthmatic airway.
Rhinoviruses bind to the ICAM-1 receptor
of the epithelial cell, a receptor whose
expression maybe altered bypollutant expo-
sure. Rhinovirus increases ICAM expression
and potentiates histamine release and
eosinophil recruitment. Cytokines detected
in nasal aspirates following rhinovirus infec-
tion include TNFa, IL-11, interferon-y, IL-
la, and chemokines IL-8, RANTES, and
MIPla. Rhinovirus infection can induce
prolonged increases in airwayhyperreactivity
and induce alate response to the antigen.
Environmental factors alter the compo-
sition and fate ofaeroallergens. Interesting
data were presented indicating that the
bioavailability of grass antigen in pollen
grains can be markedly altered by increased
humidity, sulfate exposure, and NO2 expo-
sure. Pollen may complex with ambient
particulate pollution, thus altering the
exposure characteristics and possibly the
biological response to these agents.
General discussion returned to the two
fundamental questions. First, do environ-
mental pollutants cause asthma? Although
participants recognized that the causes of
asthma are unknown, ecological comparison
(e.g., Northern vs. Southern Hemisphere;
East vs. West Germany studies) demon-
strates regional differences in atopic sensitiza-
tion and asthma implicating environmental
factors in the broadest sense. Unfortunately,
only limited data address the role ofair pol-
lution in the initiation of asthma.
Nevertheless, epidemiologic findings have
identified a possible role for ozone in adult-
onset asthma, but only in males. Second, can
environmental pollutants exacerbate asthma?
In general, it was felt that the more robust
data sets indicate that photochemical air pol-
lution (induding ozone) can exacerbate asth-
ma. The potential mechanisms of ozone-
induced exacerbations were enumerated and
included altered viral infectivity (e.g.,
through up regulation of the ICAM-1 rhi-
novirus receptor) and shifting the baseline or
antigen-inducedcytokineprofile.
SummaryofResearch
Recommendations
The group was unanimous in recommend-
ing a broad-based approach to studying
asthma and the environment. Basic
immunologic, genetic, molecular, and cel-
lular studies, epidemiologic investigation,
animal models, and controlled human
exposures are all important parts of the
research armamentarium. There was agree-
ment that environmental factors may be
exacerbating asthma, although inadequate
data for linking air pollution exposure in
the initiation of asthma exist (except in
occupational settings).
Therefore, it is recommended that
research into environmental factors associat-
ed with the initiation ofasthma, particularly
among infants and young children, should
be expanded. While the evidence that ambi-
ent air pollutants and other environmental
factors can exacerbate asthma is reasonably
strong, the role ofthese factors in inducing
the asthmatic state is unknown. The role of
viruses, cigarette smoke, and allergens in
both young children and adults should be
emphasized, in order to understand their
contribution to the inflammatory response
of epithelium and the cytokines generated.
Epidemiologic investigations should address
incidence and consequences ofviral respira-
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tory infections during high levels of pollu-
tants, as well as interactions ofallergens and
viruses in causing and exacerbating asthma.
Animal models are now available for
studying biological mechanisms responsible
for the sensitization phase of asthma. The
potential role of "knock-out" animals in
better understanding contributions ofenvi-
ronmental pollutants should be valuable.
Additional work is needed to determine the
genetic markers of individuals at risk for
developing pollutant-related effects.
More information is needed on the
dosimetry ofgaseous and particulate-matter
pollutants in asthmatics. While the dosime-
try is reasonably well understood in the
normal lung, there is much less information
available in mild to severe asthmatics. This
may be ofconsiderable importance in estab-
lishing a mechanism to explain this associa-
tion ofparticulate matter and asthma exac-
erbations and hospitalizations.
Finally, the opportunity now exists to
study injury and repair in asthma at the
cellular and molecular level. The role of
airway injury in maintaining persistent
asthma is unknown. In addition, whereas
airway inflammation is known to be associ-
ated with airway hyperreactivity, the link
with faulty epithelial repair with persistent
asthma has not been made. It was felt that
many ofthese issues could be addressed in
animal models and eventually extended to
human studies.
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TheAmerican Health Foundation's 5th International Course on the SafetyAssessment of
Medicines, Part 1 Regulatory Aspects, is designed mainly for scientists of the pharmaceutical
industry in charge ofnonclinical or clinical studies and also for those responsible for the
registration of new drugs. Participants will receive the scientific information necessary for a
sound comprehension ofthe results ofnonclinical safety studies. Toxicologists and toxicologic
pathologists will also benefit from this Coursebyupdating their knowledge. The course will be
held on October 19-24, 1997 at the Crowne Plaza in the heart ofWhite Plains, NewYork, just 35
minutes north of New York City.
For a brochure and registration information, please contact
Nancy Rivera at theAmerican Health Foundation, 1 Dana Road, Valhalla, NY 10595-1599.
Telephone: 914-789-7144, Fax: 914-592-6317.
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